BackBiotech Acquisition Co - Warrants (30/11/2027) Overview

Biotech Acquisition Co - Warrants (30/11/2027) Current Assets

Biotech Acquisition Co - Warrants (30/11/2027)'s current assets is $95K.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$95252.00
↓ 85.87% YoYΔ $-578907.00 vs prior year quarter

Peer average

Loading

Biotech Acquisition Co - Warrants (30/11/2027) Current Assets History

Loading

Biotech Acquisition Co - Warrants (30/11/2027) vs. peers: Current Assets Comparison

Loading

Biotech Acquisition Co - Warrants (30/11/2027) Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Biotech Acquisition Co - Warrants (30/11/2027) (BIOTW) FAQ

As of the most recent data (September 2022), BIOTW shows a current assets of $95K. That compares with $670K in the prior-year period — down 85.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIOTW's current assets is now $95K (was $670K) — a 85.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Biotech Acquisition Co - Warrants (30/11/2027) is outperforming or lagging.

Tracking BIOTW's current assets over time shows whether Biotech Acquisition Co - Warrants (30/11/2027) is scaling, shrinking, or reshaping that part of the business. The current reading is $95K That compares with $670K in the prior-year period — down 85.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Biotech Acquisition Co - Warrants (30/11/2027)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $95K) with ownership activity and broader fundamentals.